UBS Stays Bullish on Tenet as Conifer Ownership and Contract Terms Shift
UBS has kept its Buy rating and $260.00 price target on Tenet Healthcare (NYSE: THC) after Tenet announced that CommonSpirit will redeem its 23.8% stake in Conifer Health and will wind down its service contract at the end of 2026. The CommonSpirit relationship currently accounts for roughly $190 million of annual adjusted EBITDA attributable to Con…